BioLineRx Receives Orphan Drug Designation From the FDA for its Lead Therapeutic Candidate BL-8040 for the Treatment of Pancreatic Cancer

Stock Information for BioLineRx Ltd.

Loading

Please wait while we load your information from QuoteMedia.